Maxigen Biotech Inc.(TW:1783)
NT$36.00+0.75 (+2.13%)
TW:1783
Maxigen Biotech Inc. financials statements
NT$36.00
At close:+0.75 (+2.13%)
Maxigen Biotech Inc. (1783) Income Statement
Maxigen Biotech Inc. Income Statement
Last quarter (Q2 2026), Maxigen Biotech Inc.'s total revenue was NT$221.01M, an increase of 5.84% from the same quarter last year. In Q2, Maxigen Biotech Inc.'s net income was NT$79.13M. See Maxigen Biotech Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 811.56M | NT$ 680.65M | NT$ 622.12M | NT$ 604.43M | NT$ 511.98M | |
| NT$ 563.72M | NT$ 483.32M | NT$ 424.09M | NT$ 373.99M | NT$ 261.03M | |
| NT$ 302.68M | NT$ 288.95M | NT$ 274.24M | NT$ 240.66M | NT$ 168.06M | |
| Depreciation and Amortization | NT$ 32.14M | NT$ 27.02M | NT$ 27.62M | NT$ 29.58M | NT$ 32.90M |
| NT$ 293.18M | NT$ 221.40M | NT$ 177.09M | NT$ 195.43M | NT$ 130.56M | |
| NT$ 261.04M | NT$ 194.38M | NT$ 149.85M | NT$ 170.56M | NT$ 100.69M | |
| NT$ 43.85M | NT$ 45.64M | NT$ 43.29M | NT$ -4.78M | NT$ -3.22M | |
| NT$ 304.89M | NT$ 225.54M | NT$ 193.14M | NT$ 165.78M | NT$ 97.47M | |
| NT$ 265.31M | NT$ 190.17M | NT$ 165.83M | NT$ 139.40M | NT$ 87.67M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 2.96 | NT$ 2.13 | NT$ 1.86 | NT$ 1.57 | NT$ 1.05 |
| Diluted EPS | NT$ 2.96 | NT$ 2.12 | NT$ 1.85 | NT$ 1.56 | NT$ 1.04 |
| Weighted Average Shares Outstanding | 89.63M | 89.10M | 89.15M | 88.93M | 83.76M |
| Weighted Average Shares Outstanding (Diluted) | 89.63M | 89.70M | 89.45M | 89.41M | 84.06M |
Currency in TWD
